The Davistown Museum

(Nancy Kaufman) #1

Valdez, L., Rêgo, H., Stanley, H. and Braunstein, L. (2015). Predicting the extinction of
Ebola spreading in Liberia due to mitigation strategies. Quantitative Biology.
http://arxiv.org/abs/1502.01326


Van Loon, H. J., Vriens, M. R., Fluit, A. C., et al. (2004). Antibiotic rotation and
development of gram-negative antibiotic resistance. American Journal of Respiratory
Critical Care Medicine. 171(5). pg. 480-87.
http://www.atsjournals.org/doi/abs/10.1164/rccm.200401-070OC#.VsigQfkrLmg



  • “Cycling of homogeneous antibiotic exposure is unlikely to control the
    emergence of gram-negative antimicrobial resistance in intensive care units.”


Voyles, J., et al. (2014). Moving beyond too little, too late: Managing emerging
infectious diseases in wild populations requires international policy and partnerships.
EcoHealth.
https://nature.berkeley.edu/rosenblum/Rosenblum%20Lab%20UC%20Berkeley%20ES
PM%20-%20Publications_files/Voyles_EcoHealth_2014.pdf



  • “Emerging infectious diseases (EIDs) are on the rise due to multiple factors,
    including human facilitated movement of pathogens, broad-scale landscape
    changes, and perturbations to ecological systems (Jones et al. 2008; Fisher et al
    2012).”

  • “Epidemics in wildlife are problematic because they can lead to pathogen
    spillover to new host organisms, erode biodiversity and threaten ecosystems that
    sustain human societies.”


Waggoner, J. J., Soda, E. A. and Deresinski, S. (2013). Rare and emerging viral
infections in transplant recipients. Immunocompromised Hosts. 57(8). pg. 1182-88.
http://cid.oxfordjournals.org/content/57/8/1182.full



  • “Rare and emerging viruses in the transplant population [include]: human T-cell
    leukemia virus type 1; hepatitis E virus; bocavirus; KI and WU polyomaviruses;
    coronaviruses HKU1 and NL63; influenza, H1N1; measles, dengue; rabies; and
    lymphocytic choriomeningitis virus. Detection and reporting of such rare
    pathogens in transplant recipients is critical to patient care and improving our
    understanding of posttransplant infections.”


Walker, B., Barrett, S., Polasky, S., et al. (2009). Looming global-scale failures and
missing institutions. Science. (325). pg. 1345-46.
http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=19745137


Walsh C. (2000). Molecular mechanisms that confer antibacterial drug resistance.
Nature. 406(6797). pg. 775-81. http://www.ncbi.nlm.nih.gov/pubmed/10963607

Free download pdf